Building on our 45 year heritage in respiratory research, we remain relentless in our pursuit to improve the outcomes for patients with asthma and COPD.
Alongside inhaled approaches, where the focus is on helping patients achieve good control of their symptoms, we are developing the next generation of treatments – novel biologics and medicines that target the underlying causes of disease. Beyond asthma and COPD, we are actively exploring treatments for other respiratory diseases, such as idiopathic pulmonary fibrosis and acute lung injury.
In the future, improvements in the treatment of respiratory diseases will come not only from new medicines but also from innovations in patient care, including adherence and treatment personalisation.”
Explore more features
Take a deep breath – your lung microbiome will appreciate it
Respiratory disease: why we want to make a difference
Today too many people suffer unnecessarily because of the poor management of their asthma and COPD.
We have embarked on a pioneering new asthma remission study at the Centre for Therapeutic Target Validation.
Helping to further science and research – Howard’s perspective
The Salford Lung Study is a ground breaking clinical trial that explores how effective a treatment for COPD is in everyday life.
Inhaler innovation: more than a simple piece of plastic
Most of us will know someone who suffers from asthma and uses an inhaler regularly to control their condition.
An 'everyday' world first in clinical trials
More on areas of research
In the past 25 years, a steady increase in bacteria immune to antibiotics has become a serious threat to global public health
A new scientific field that could one day result in a novel class of miniaturised, implantable device medicines
A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III
50 years of R&D innovation
Learn more about our R&D legacy involving the development of a broad range of innovative medicines, vaccines and consumer healthcare products